Clinical Trials
ImmunoGen begins Phase I cancer trial of IMGN853
ImmunoGen has announced the commencement of the Phase I trial of IMGN853 in ovarian cancer and other solid tumours over-expressing its folate receptor target,...
Clinical Trials
Dyax reports interim analysis data of Phase 2 ecallantide...
Dyax has reported interim analysis results of Phase 2 trial of ecallantide for acute treatment of angiotensin converting enzyme (ACE) inhibitor-induced angioedema. ...
Clinical Trials
Quest PharmaTech to start Phase II Oregovomab clinical trial
Quest PharmaTech has got clearance from FDA to initiate US sites for an ongoing international Phase II clinical trial for oregovomab in advanced ovarian...
Clinical Trials
Bayer, Onyx Phase III NSCLC trial fails to meet...
Bayer HealthCare Pharmaceuticals and Onyx Pharmaceuticals have announced that Phase III trial of Nexavar  in non-small cell lung cancer patients did not meet primary...
Clinical Trials
Active Biotech, Ipsen reach EUR10m milestone in Phase III...
Active Biotech and Ipsen have announced the recruitment of 600 patients in randomized, placebo-controlled Phase III study of tasquinimod in metastatic castrate-resistant prostate cancer...
Clinical Trials
Peregrine reports results from phase II front-line lung cancer...
Peregrine Pharmaceuticals has announced results from its randomized phase II trial, which is designed to determine overall response rate of carboplatin and paclitaxel with...
Clinical Trials
Circassia reports positive results from Phase II ragweed allergy...
 Circassia, a specialty biopharmaceutical company, has announced positive results from Phase II clinical trial of ragweed allergy therapy.  According to...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.